Macquarie Group Limited 13D and 13G filings for Pacira BioSciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 1:31 pm Sale | 2022-12-30 | 13G | Pacira BioSciences, Inc. PCRX | Macquarie Group Limited | 2,037,049 4.440% | -2,168,473 (-51.56%) | Filing |
| 2022-02-14 10:05 am Purchase | 2021-12-31 | 13G | Pacira BioSciences, Inc. PCRX | Macquarie Group Limited | 4,205,522 9.440% | 1,452,880 (+52.78%) | Filing |
| 2021-02-12 08:40 am Purchase | 2020-12-31 | 13G | Pacira BioSciences, Inc. PCRX | Macquarie Group Limited | 2,752,642 6.340% | 680,468 (+32.84%) | Filing |
| 2020-02-13 10:45 am Sale | 2019-12-31 | 13G | Pacira BioSciences, Inc. PCRX | Macquarie Group Limited | 2,072,174 4.970% | -64,158 (-3.00%) | Filing |